In vitro hypercoagulability and ongoing in vivo activation of coagulation and fibrinolysis in COVID‐19 patients on anticoagulation

BACKGROUND: COVID‐19 is associated with a substantial risk of venous thrombotic events, even in the presence of adequate thromboprophylactic therapy. OBJECTIVES: We aimed to better characterize the hypercoagulable state of COVID‐19 patients in patients receiving anticoagulant therapy. METHODS: We to...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:J Thromb Haemost
Główni autorzy: Blasi, Annabel, von Meijenfeldt, Fien A., Adelmeijer, Jelle, Calvo, Andrea, Ibañez, Cristina, Perdomo, Juan, Reverter, Juan C., Lisman, Ton
Format: Artigo
Język:Inglês
Wydane: The Authors. Journal of Thrombosis and Haemostasis published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis 2020
Hasła przedmiotowe:
Brief Report
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7436627/
https://ncbi.nlm.nih.gov/pubmed/32762118
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.15043
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy